Imatinib mesylate (Gleevec): targeted therapy against cancer with immune properties
| Image |  |
|---|---|
| Description | scientific article published on March 2010 |
| Author/s | |
| Publication date | March 1, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |